Company / R&D Expense
IMMUCELL CORP /DE/ R&D Expense History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$3.9M
FY2025
5-year range
$1.2M / $4.5M
FY2021-FY2025
Trend
-11.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has fluctuated over the past 10 years, ranging from $917,600 in FY2014 to $4M in FY2023.
Based on SEC 10-K filings.
$4M in FY2025 with a 10-year CAGR of +12.9%.
Declined from $4M to $4M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +12.9%
Key checks
Key Insights
- In FY2025, r&d expense decreased 11.3% year-over-year.
- Peak r&d expense was recorded in FY2023.
- Lowest r&d expense in the period was in FY2014.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.9M | -11.3% |
| FY2024 | $4.4M | -2.2% |
| FY2023 | $4.5M | +261.1% |
| FY2017 | $1.2M | +0.7% |
| FY2016 | $1.2M | +7.0% |
| FY2015 | $1.2M | +25.8% |
| FY2014 | $917.6K | -46.7% |
| FY2013 | $1.7M | +15.2% |
| FY2012 | $1.5M | -9.2% |
| FY2011 | $1.6M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026